Additionally, research focused on the mechanisms behind the beneficial effects of these interventions—such as their impact on hepatic steatosis, inflammation, insulin resistance, and gut microbiota composition—will provide deeper insights into the role of nutrition in managing MASLD. This evidence concerns the gene INS and Hepatic steatosis.